AI-generated summary
The authors reanalyzed a randomized trial comparing bright light therapy with dim red light in patients with depression, using MRI-based brain age estimates. Both groups improved on depression scores without significant between-group differences, and the authors found no specific effect of bright light therapy on brain age. Reduced brain age was associated with subjective symptom improvement, which the authors suggest may reflect placebo effects or neuroplasticity.
- Who or what was studied
- Patients with depression in a double-blind randomized controlled trial (21 in the bright light therapy group and 18 in the dim red light group)
- Limits stated in the abstract
- The sample was small, the analysis was a reanalysis of a trial, and the authors note that subjective improvement may reflect placebo effects rather than a specific treatment effect.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Depression, Bright light therapy, Placebo effect, Randomized controlled trial, Neuroplasticity, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.